DZ Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History

DZ Bank’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-16,800	Closed	-$334K	–	1052
2018 Q1	$334K	Buy	+16,800	New	+$446K	﹤0.01%	858

Other funds holding RYTM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DZ Bank's RYTM Position: Q2 2018 in Review

DZ Bank sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2018, closing a stake of 16,800 shares — an estimated $334K sold.

DZ Bank first reported a position in RYTM in Q1 2018 and held it in 1 quarter. The position peaked at $334K in Q1 2018. 85 funds tracked by Wall St. Rank hold RYTM as of Q2 2018.

DZ Bank reported no remaining Rhythm Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 16,800 Rhythm Pharmaceuticals shares in Q2 2018, an estimated $334K.
DZ Bank first reported a position in Rhythm Pharmaceuticals in Q1 2018 and held it in 1 quarter.
DZ Bank's Rhythm Pharmaceuticals position peaked at $334K in Q1 2018.
85 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.